The text discusses the validation of the V600E mutation for stage II colon cancer, the evaluation of an immunoscore for lymphocytic infiltration, and the prognostic value of these scores in localized colon cancer. It also mentions the evaluation of other histoprognostic scores and the consensus on molecular subtypes of colorectal cancer.